Risk factors for comorbidities in Czech psoriatic patients: Results of a hospital-based case-control study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F14%3A10292892" target="_blank" >RIV/00216208:11130/14:10292892 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064211:_____/14:#0000365
Výsledek na webu
<a href="http://dx.doi.org/10.5507/bp.2013.062" target="_blank" >http://dx.doi.org/10.5507/bp.2013.062</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2013.062" target="_blank" >10.5507/bp.2013.062</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Risk factors for comorbidities in Czech psoriatic patients: Results of a hospital-based case-control study
Popis výsledku v původním jazyce
Background. Psoriasis is now known to be associated with multiple other diseases/comorbidities - including the metabolic syndrome, atherosclerosis and gastrointestinal diseases which are all significantly higher in psoriasis patients. Research results however are highly variable and the conclusions are ambiguous. As no similar study has been performed to date in Czech psoriatic patients, this study aimed at identifying risk factors and early stages of selected diseases/comorbidities in the patients. Methods and Results. The study was designed as a hospital-based case-control study. 131 patients with chronic plaque psoriasis formed the cases and 267 patients with other skin disorders formed the controls. A comparison was made of basic demographic and anthropometric indicators, metabolic parameters, the presence of specific antibodies (ASCA, AEP, p-ANCA, AGC, EMA, ARA, t-TG, AGA) and non-specific signs of gastrointestinal diseases. The chi squared, MWU tests and binary logistical model w
Název v anglickém jazyce
Risk factors for comorbidities in Czech psoriatic patients: Results of a hospital-based case-control study
Popis výsledku anglicky
Background. Psoriasis is now known to be associated with multiple other diseases/comorbidities - including the metabolic syndrome, atherosclerosis and gastrointestinal diseases which are all significantly higher in psoriasis patients. Research results however are highly variable and the conclusions are ambiguous. As no similar study has been performed to date in Czech psoriatic patients, this study aimed at identifying risk factors and early stages of selected diseases/comorbidities in the patients. Methods and Results. The study was designed as a hospital-based case-control study. 131 patients with chronic plaque psoriasis formed the cases and 267 patients with other skin disorders formed the controls. A comparison was made of basic demographic and anthropometric indicators, metabolic parameters, the presence of specific antibodies (ASCA, AEP, p-ANCA, AGC, EMA, ARA, t-TG, AGA) and non-specific signs of gastrointestinal diseases. The chi squared, MWU tests and binary logistical model w
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FO - Dermatovenerologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT13275" target="_blank" >NT13275: Rizikové faktory komorbidit psoriázy využitelné v sekundární prevenci</a><br>
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Svazek periodika
158
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
7
Strana od-do
288-294
Kód UT WoS článku
000338628200020
EID výsledku v databázi Scopus
—